• Admittance is an instrumentation design company that can take advantage of the technology already implanted in patients, with the goal of improving their care.
  • Admittance Technologies is committed to improving the quality of life of patients with heart disease through innovative electrical engineering solutions.
  • For patients with B-Vi pacemakers, CardioVol is the optimal solution for heart failure management. If detected early enough, accelerated treatment using drugs (often ACE inhibitors) could prevent heart failure and an additional hospital visit.
  • Admittance's IP portfolio and engineering prototypes are the evolution of a collaborative research program at the University of Texas for the last 14 years. The research produced by these groups has been published in multiple journals.

Admittance Technologies

Admittance Technologies is committed to improving the quality of life of patients with heart disease through innovative electrical engineering solutions. Admittance will accomplish this goal through the application of CardioVol™, which can interrogate the heart with electric fields, and in real-time provide ventricular volume data including relative stroke volume. We focus on the blood signal to warn patients of impending heart failure, maximize their hearts’ ejection of blood by properly tuning the pacing of these weakened hearts, and using stroke volume to determine if VT is hemodynamically unstable, requiring defibrillation.

Admittance Technologies is committed to improving the quality of life of patients with heart disease through innovative electrical engineering solutions.